Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insulin Resistance Phenotypes

Обзор

The focus of this cross-sectional study is to determine the effects of tissue-specific (adipose tissue or muscle) vs global (combined) insulin resistance (IR) on hepatic triglyceride biosynthesis in humans, and to determine differential effects of an acute exercise intervention on hepatic triglyceride biosynthesis in these groups.

Подробное описание

Hypothesis: Patients who primarily have muscle IR will have a greater percentage of lipids derived from de novo lipogenesis (DNL) than patients with combined muscle and adipose IR, and these subjects will respond more robustly to the effects of premeal exercise.

With this study, the investigators will demonstrate that the mechanisms that drive triglyceride overproduction in insulin-resistant humans are dependent on which tissues are insulin resistant. To this end, investigators will determine whether subjects with muscle insulin resistance and adipose tissue insulin resistance utilize different mechanisms of triglyceride biosynthesis to assemble hepatic very low density lipoprotein (VLDL), as compared with individuals with muscle insulin resistance but relative adipose tissue insulin sensitivity. Additionally, investigators will see if adipose tissue insulin sensitivity predicts exercise responsiveness of hepatic triglyceride production.

Main study parameters/endpoints: Difference in %DNL between subjects with global vs muscle-only insulin resistance as well as the differential effects of premeal exercise on %DNL in these groups.

Вмешательства

• Поведенческое Standardized Dinner
  De novo lipogenesis (DNL) will be assessed in all participants with a standardized dinner
• Поведенческое Premeal exercise
  DNL will be assessed in all participants with short bouts of premeal exercise with a standardized dinner

Первичные конечные точки

• Effect of tissue-specific insulin resistance on contribution of DNL to plasma triglyceride [Срок оценки: Baseline]
• Change in DNL in VLDL-triglycerides after a standard meal compared to a standard meal with premeal exercise. [Срок оценки: study visit 1 and study visit 2, up to 8 weeks]

Вторичные конечные точки (4)

• Change in plasma triglycerides after a standard meal compared to a standard meal with premeal exercise [Срок оценки: study visit 1 and study visit 2, up to 8 weeks]
• Baseline plasma triglycerides [Срок оценки: baseline]
• Adipose insulin sensitivity [Срок оценки: Baseline]
• Skeletal muscle/whole-body insulin sensitivity assessed by oral glucose tolerance test (OGTT) [Срок оценки: Baseline]

Критерии участия

Критерии включения

• Ability to give informed consent
• Overweight, defined as BMI 25-30 kg/m2
• Modest hypertriglyceridemia, defined as fasting plasma triglycerides 1.5-3.0mM
• High risk of insulin resistance, defined as fasting plasma insulin >64pM
• Stable weight for at least 3mo prior to participation

Критерии исключения

• Active or chronic liver disease, kidney disease, congestive heart failure, unstable angina, history of acute cardiovascular events within 6mo of screening, history of seizures or syncope, or an active infection requiring antimicrobial therapy;
• Use of insulin, thiazolidinediones, SGLT2 inhibitors, or sulfonylureas;
• Use of fibrates, omega 3 (fish oil), niacin, or PCSK9 antagonists;
• Use of systemic glucocorticoids within 60d prior to participation;
• Hematocrit <35%;
• Pregnancy of breastfeeding;
• Active tobacco use, excessive alcohol intake (>14U/wk), or history of drug abuse.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Перекрёстный дизайн

Маскирование

Открытое

Основная цель

Фундаментальное исследование

Центры проведения

Нидерланды · 1 центр

• AMC Amsterdam — Amsterdam

Идентификаторы

NCT: NCT05743868 · Vatner 012523 · NL83166.018.22 · R01DK124272

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗